Accelerated immunosenescence in rheumatoid arthritis: impact on clinical progression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4933
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Accelerated immunosenescence in rheumatoid arthritis: impact on clinical progression ; volume:17 ; number:1 ; day:9 ; month:3 ; year:2020 ; pages:1-14 ; date:12.2020
Immunity & ageing ; 17, Heft 1 (9.3.2020), 1-14, 12.2020
- Creator
-
Bauer, Moisés E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12979-020-00178-w
- URN
-
urn:nbn:de:101:1-2020060405215709707870
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bauer, Moisés E.
- SpringerLink (Online service)
Other Objects (12)
Accelerated diastolic dysfunction in premenopausal women with rheumatoid arthritis
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis
Clinical results of synovectomy in rheumatoid arthritis
Rheumatoid arthritis
Rheumatoid arthritis, [1]
Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients
Synovial microenvironment-influenced mast cells promote the progression of rheumatoid arthritis
Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events
Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials
Clinical and subclinical neuropsychiatric abnormalities in rheumatoid arthritis patients
Accelerated diastolic dysfunction in premenopausal women with rheumatoid arthritis
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis
Clinical results of synovectomy in rheumatoid arthritis
Rheumatoid arthritis
Rheumatoid arthritis, [1]
Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients
Synovial microenvironment-influenced mast cells promote the progression of rheumatoid arthritis
Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events
Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials
Clinical and subclinical neuropsychiatric abnormalities in rheumatoid arthritis patients
Accelerated diastolic dysfunction in premenopausal women with rheumatoid arthritis
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis
Clinical results of synovectomy in rheumatoid arthritis
Rheumatoid arthritis
Rheumatoid arthritis, [1]
Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients
Synovial microenvironment-influenced mast cells promote the progression of rheumatoid arthritis
Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events
Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials